Rezolute's stock plunges 87% after hypoglycemia drug flunks pivotal phase 3 test
Rezolute's stock plunges 87% after hypoglycemia drug flunks pivotal phase 3 test
本文は利用できません。元の情報源をご確認ください。
Rezolute's stock plunges 87% after hypoglycemia drug flunks pivotal phase 3 test